What's breaking now, across thousands of outlets.
Pfizer halts Phase 2 autoimmune trial: The study was testing a program called PF-06835375 in the rare autoimmune disorder primary immune thrombocytopenia. The federal clinical trials database noted the halt was ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
EV deliveries surged 96% as company pivots to asset-light manufacturing in Vietnam.
Nike's dividend yield is flashy, but Coca-Cola and Procter & Gamble offer more stability.
EUR/USD extends its intraday advance during American trading hours on Tuesday as Oil prices reverse sharply following reports of progress toward renewed US-Iran negotiations, pushing the US Dollar…
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Direxion Daily TSLA Bull 2X ETF (Symbol: TSLL) where we have detected…
TransUnion (NYSE: TRU) today announced the launch of its Credit Washing and Synthetic Fraud Scores with adverse action capability.
